Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H32O5 |
| Molecular Weight | 364.4758 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC(=O)[C@H]3[C@@H](CC[C@@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
InChI
InChIKey=SYGWGHVTLUBCEM-ZIZPXRJBSA-N
InChI=1S/C21H32O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12-15,18,22-23,26H,3-11H2,1-2H3/t12-,13-,14+,15+,18-,19+,20+,21+/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effect of high level tennis matches on urine steroid profiles in professional tennis players. | 2010-12 |
|
| Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). | 2010-08 |
|
| Potential corticoid metabolites: chemical synthesis of 3- and 21-monosulfates and their double-conjugates of tetrahydrocorticosteroids in the 5alpha- and 5beta-series. | 2010-03 |
|
| Intense physical exercise increases systemic 11beta-hydroxysteroid dehydrogenase type 1 activity in healthy adult subjects. | 2010-03 |
|
| HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids. | 2010-02-01 |
|
| 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension. | 2010-02 |
|
| Altered urinary profiles of endogenous steroids in postmenopausal women with adenocarcinoma endometrii. | 2010-01 |
|
| Steroid assays in paediatric endocrinology. | 2010 |
|
| Simultaneous determination of twelve tetrahydrocorticosteroid glucuronides in human urine by liquid chromatography/electrospray ionization-linear ion trap mass spectrometry. | 2009-12-15 |
|
| Determination of endocrine disrupting compounds using temperature-dependent inclusion chromatography: I. Optimization of separation protocol. | 2009-10-30 |
|
| Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. | 2009-10 |
|
| Heritable forms of hypertension. | 2009-10 |
|
| Application of hyphenated mass spectrometry techniques for the analysis of urinary free glucocorticoids. | 2009-09 |
|
| Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity. | 2009-09 |
|
| Effect of apolipoprotein a-I complex with tetrahydrocortisone on protein biosynthesis and glucose absorption by rat hepatocytes. | 2009-08 |
|
| Urinary steroid profile after the completion of concentric and concentric/eccentric trials with the same total workload. | 2009-06 |
|
| Recent advances in the assessment of the ratios of cortisol to cortisone and of some of their metabolites in urine by LC-MS-MS. | 2009-04 |
|
| Isotope ratio mass spectrometry analysis of the oxidation products of the main and minor metabolites of hydrocortisone and cortisone for antidoping controls. | 2009-03 |
|
| Diagnosis of diseases of steroid hormone production, metabolism and action. | 2009 |
|
| Cortisol metabolism in depressed patients and healthy controls. | 2009 |
|
| Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children. | 2008-12-22 |
|
| Evaluation of urinary steroid profile in highly trained cyclists. | 2008-12 |
|
| Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. | 2008-10 |
|
| Simultaneous determination of tetrahydrocortisol, allotetrahydrocortisol and tetrahydrocortisone in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. | 2008-08 |
|
| Determination of urine steroid profile in untrained men to evaluate recovery after a strength training session. | 2008-07 |
|
| 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. | 2008-06 |
|
| Development of a liquid chromatography-tandem mass spectrometry method for the determination of 23 endogenous steroids in small quantities of primate urine. | 2008-02-01 |
|
| Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor. | 2008-02 |
|
| Simultaneous measurements of urinary free cortisol and cortisone for the assessment of functional glucocorticoid activity. | 2007-10 |
|
| Endogenous corticosteroid biosynthesis in subjects after bilateral adrenalectomy. | 2007-05 |
|
| Sex-specific difference in the interconversion of cortisol and cortisone in men and women. | 2007-04 |
|
| Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. | 2007-03 |
|
| Variations in urine excretion of steroid hormones after an acute session and after a 4-week programme of strength training. | 2007-01 |
|
| [The urinary index of intracellular glucocorticoid reactivation--a novel marker of metabolic syndrome and type 2 diabetes]. | 2006-12-28 |
|
| Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. | 2006-11 |
|
| No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men. | 2006-08 |
|
| Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome. | 2006-07-27 |
|
| RP-HPLC method with fluorescence detection for determination of small quantities of triamcinolone in plasma in presence of endogenous steroids after derivatization with 9-anthroyl nitrile; pharmacokinetic studies. | 2006-07-24 |
|
| Pediatric renal allograft transplantation does not normalize the increased cortisol/cortisone ratios of chronic renal failure. | 2006-04 |
|
| Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. | 2006-02 |
|
| Direct determination of the ratio of tetrahydrocortisol+allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS. | 2006-01-18 |
|
| Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients. | 2006-01 |
|
| Determination of free tetrahydrocortisol and tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry. | 2006 |
|
| 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. | 2005-03 |
|
| Comparison of the analysis of corticosteroids using different techniques. | 2005-01 |
|
| Activity of 11beta-hydroxysteroid dehydrogenase type 2 in normotensive blacks and whites. | 2005 |
|
| Urinary steroid excretion rates in acromegaly. | 2005 |
|
| Production rates of cortisol in obesity. | 2004-09 |
|
| Glucocorticoids contribute to the heritability of leptin in Scottish adult female twins. | 2004-07 |
|
| Endogenous urinary steroids in premenopausal women with uterine leiomyomas. | 2004-01 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
82894-7
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82895-4
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82851-7
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
73894-8
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82896-2
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82878-0
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82901-0
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82879-8
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82849-1
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82848-3
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82857-4
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82862-4
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82855-8
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82900-2
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82899-6
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82854-1
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
81795-7
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82856-6
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82861-6
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82898-8
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
73893-0
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82850-9
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
||
|
LOINC |
82897-0
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70878591
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
TETRAHYDROCORTISONE
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
300000055548
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
m10625
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | Merck Index | ||
|
5866
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
5HF9TM2D15
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
200-161-9
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
53-05-4
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY | |||
|
76984
Created by
admin on Mon Mar 31 17:32:54 GMT 2025 , Edited by admin on Mon Mar 31 17:32:54 GMT 2025
|
PRIMARY |
PARENT (METABOLITE)
SUBSTANCE RECORD